Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $160.39 +1.33%
EPS Growth %: -5.5%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -5.5%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18).
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Tutor Perini launches $400M senior notes offering due 2033
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
